| LncRNA |
Compound |
Cancer |
P-value |
Effect |
| ENSG00000260269.1 |
SB216763 |
Chronic Lymphocytic Leukemia |
0.018637502 |
Resistant |
| ENSG00000260269.1 |
SB216763 |
Brain lower grade glioma |
0.039782788 |
Resistant |
| ENSG00000260269.1 |
SB216763 |
Pancreatic adenocarcinoma |
0.008921594 |
Resistant |
| ENSG00000260269.1 |
SB216763 |
Bladder urothelial carcinoma |
0.011090085 |
Sensitive |
